What is the best clinical pathological score to identify high-risk patients with lobular carcinoma of the breast who are likely to benefit from adjuvant chemotherapy?

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)231-232
Number of pages2
JournalBreast Cancer Research and Treatment
Issue number1
Publication statusPublished - Aug 30 2019

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this